Oruka To Present At Piper Sandler’s 36th Healthcare Conference
19 Nov 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Reports Q3 2024 Results & Corporate News
13 Nov 2024 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at Multiple November Investor Conf
04 Nov 2024 //
GLOBENEWSWIRE
Oruka Presents ORKA-001 Preclinical Data At EADV Congress
25 Sep 2024 //
GLOBENEWSWIRE
Oruka Announces ORKA-001 Timelines And EADV Presentation
12 Sep 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Announces $200 Million Private Placement
12 Sep 2024 //
GLOBENEWSWIRE
Oruka Therapeutics Closes Merger with ARCA biopharma, Raises $275 Million
03 Sep 2024 //
GLOBENEWSWIRE
ARCA Biopharma Completes Merger with Oruka and Reverse Stock Split
29 Aug 2024 //
GLOBENEWSWIRE
ARCA Biopharma Updates Special Dividend Amount in Merger with Oruka Therapeutics
26 Aug 2024 //
GLOBENEWSWIRE
ARCA Biopharma Updates Special Dividend For Oruka Therapeutics Merger
26 Aug 2024 //
GLOBENEWSWIRE
ARCA Biopharma Announces 1-For-12 Reverse Stock Split For Oruka Merger
23 Aug 2024 //
GLOBENEWSWIRE
ARCA Biopharma Declares Special Dividend, Merger With Oruka Therapeutics
16 Aug 2024 //
GLOBENEWSWIRE
Oruka Announces Key Additions to Leadership Team and Board of Directors
26 Jun 2024 //
GLOBENEWSWIRE
Oruka Therapeutics to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Oruka Expands Leadership With Senn, Panwar Appointments
22 May 2024 //
GLOBENEWSWIRE
Oruka Expands Leadership, Appoints Joana Goncalves as CMO
24 Apr 2024 //
GLOBENEWSWIRE